| Literature DB >> 33212200 |
Abdul Rouf Wani1, Kanchan Yadav2, Aadil Khursheed3, Manzoor Ahmad Rather4.
Abstract
Essential oils and their chemical constituents have been reported with well documented antimicrobial effects against a range of bacterial, fungal and viral pathogens. By definition, essential oils are a complex mixture of volatile organic compounds which are synthesized naturally in different parts of the plant as part of plants secondary metabolism. The chemical composition of the essential oils is dominated by the presence of a range of compounds including phenolics, terpenoids, aldehydes, ketones, ethers, epoxides and many others inferring that essential oils must be effective against a wide range of pathogens. This review article mainly focuses on the antiviral potential of essential oils and their chemical constituents especially against influenza and coronaviruses. Essential oils have been screened against several pathogenic viruses, including influenza and other respiratory viral infections. The essential oils of cinnamon, bergamot, lemongrass, thyme, lavender have been reported to exert potent antiviral effects against influenza type A virus. The essential oil of Citrus reshni leaves has been shown to be effective against H5N1 virus. The essential oil of Lippia species at a concentration of 11.1 μg/mL has been shown to induce 100% inhibition of yellow fever virus in Vero cells. Essential oils and oleoresins have been shown through in vitro and in vivo experiments to induce antiviral effects against Coronavirus infectious bronchitis virus. A study reported 221 phytochemical compounds and essential oils to be effective against severe acute respiratory syndrome associated coronavirus (SARS-CoV) using a cell-based assay measuring SARS-CoV-induced cytopathogenic effect on Vero E6 cells. The main mechanism of antiviral effects of essential oils has been found to cause capsid disintegration and viral expansion which prevents the virus to infect host cells by adsorption via the capsid. Essential oils also inhibit hemagglutinin (an important membrane protein of various viruses) of certain viruses; this membrane protein allows the virus to enter the host cell. Many essential oils and their components could inhibit the late stages of viral life cycle by targeting the redox signalling pathway. Essential oils of Thymus vulgaris, cymbopogon citratus and Rosmarinus officinalis have been found to destabilize the Tat/TAR-RNA complex of HIV-1 virus, this complex being essential for HIV-1 replication. Being lipophilic in nature, essential oils can penetrate viral membranes easily leading to membrane disintegration. The current comprehensive review will facilitate researchers to find chemical entities from plant sources as possible inhibitory agents against various viruses.Entities:
Keywords: Antiviral; Essential oils; Influenza; Severe acute respiratory syndrome; Terpenes
Mesh:
Substances:
Year: 2020 PMID: 33212200 PMCID: PMC9159739 DOI: 10.1016/j.micpath.2020.104620
Source DB: PubMed Journal: Microb Pathog ISSN: 0882-4010 Impact factor: 3.848
Fig. 1Some of the hemiterpenes constituents of essential oils.
Fig. 2Some of the monoterpene and monoterpenoid constituents of essential oils.
Fig. 3Some of the sesquiterpenes and sesquiterpenoid constituents of essential oils.
Fig. 4Some of the diterpene and diterpenoid constituents of essential oils.
The antiviral actives of some essential oils of plant origin [126].
| S.no. | Source of essential oils | Target viruses | Mechanism type | SI | IC50 |
|---|---|---|---|---|---|
| 1 | Coxsackie virus B4 | ND | 789.8 | 2.2 μg/mL | |
| 2 | Coxsackie virus B4 | ND | 74.3 | 21.7 μg/mL | |
| 3 | HIV-1 | ND | ND | 1.2 mg/mL | |
| 4 | HIV-1 | ND | 1.13–3.6 | 0.05–0.83 μg/mL | |
| 5 | Avian influenza virus A (H5N1) | ND | ND | 6.8 μg/mL | |
| 6 | Avian influenza virus A (H5N1) | ND | 8.7 | 2.5 μg/mL | |
| 7 | IFV-A (H1N1) | Intercellular | >21 | <3.1 μL/mL | |
| 8 | IFV-A (H1N1) | Intercellular | >0.5 | <50 μL/mL | |
| 9 | IFV-A (H1N1) | Intercellular | >8 | <3.1 μL/mL | |
| 10 | IFV-A (H1N1) | Intercellular | >4 | <3.1 μL/mL | |
| 11 | IFV-A (H1N1) | ND | >4 | <3.1 μL/mL | |
| 12 | IFV-A (H1N1) | Intercellular | >5 | <3.1 μL/mL | |
| 13 | IFV-A (H1N1) | Intercellular | >4 | <3.1 μL/mL | |
| 14 | Patchouli | IFV-A (H1N1) | ND | 1.15 | 0.088 mg/mL |
| 15 | Mexican oregano ( | Acyclovir-resistant HSV-1 | Intercellular | 13.1 | 55.9 μg/mL |
| 16 | Acyclovir-resistant HSV-2 | Intercellular and intracellulara | 55.2 | 28.6 μg/mL | |
| 17 | HSV-2 | Intercellular | 6.0 | 18.6 μg/mL | |
| 18 | HSV-1 | Intercellular | 6.9 | 17.6 μg/mL | |
| 19 | HSV-1 | ND | 46.1 | 0.006% | |
| 20 | HSV-1 | ND | 32.2 | 0.008% | |
| 21 | HSV-1 | ND | 66.4 | 0.004% | |
| 22 | HSV-1 | ND | 38.8 | 0.007% | |
| 23 | HSV-1 | ND | 55.4 | 0.003% | |
| 24 | Mexican oregano ( | HSV-1 | Intercellular | 7.4 | 99.6 μg/mL |
| 25 | HSV-1 | Intercellular | 1 | 0.001% | |
| 26 | HSV-1 | Intercellular | 6.4 | 0.011% | |
| 27 | Star Anise | HSV-1 | Intercellular | 160 | 1 μg/mL |
| 28 | HSV-1 | Intracellular | 67 | 5.1 μg/mL | |
| 29 | Australian tea tree | HSV-1 | Intracellular | 43 | 13.2 μg/mL |
| 30 | HSV-1 | Intercellular | 1.5 | 0.035% |
Note: SI = selectivity index, ND = not defined, HIV = human immunodeficiency viruses, HSV = human herpes viruses, Intracellular = effects on intercellular events of life cycle in viruses, Intercellular = effects on virus surface pre or post adsorption and “a” = indicates later stages of viral lifecycle.
Antiviral activity of some individual essential oil compounds [126].
| S.no. | Compounds | Target viruses | Mechanism type | SI | IC50 |
|---|---|---|---|---|---|
| 1 | Camphor | BVDV | Intercellular | 13.9 | 318.51 μg/mL |
| 2 | 1, 8-Cineole | BVDV | Intercellular | 9.1 | 331.17 μg/mL |
| 3 | Germacrone | IFV-A (H1N1) | Intercellular and intracellularb | >41 | 6.03 μM |
| 4 | β-Santalol | IFV-A (H3N2) | Intracellulara | 10–100 μg/mL | |
| 5 | Eugenol | IFV-A (H1N1) | ND | ND | <3.1 μL/mL |
| 6 | Carvacrol | IFV-A (H1N1) | ND | <0.15 | 2.6 μg/mL |
| 7 | Carvacrol | Acyclovir-resistant HSV-1 | Intracellular | 8.7 | 28.6 μg/mL |
| 8 | Limonene | HSV-1 | Intercellular | 10.2 | 5.9 μg/mL |
| 9 | β-Pinene | HSV-1 | Intercellular | 24.3 | 3.5 μg/mL |
| 10 | Carvacrol | HSV-1 | Intercellular | 43 | 7 μM |
| 11 | Thymol | HSV-1 | Intercellular | 43 | 7 μM |
| 12 | Carvacrol | HSV-1 | Intracellular | 5.1 | 48.6 μg/mL |
| 13 | HSV-1 | Intercellular | ND | >0.1% | |
| 14 | Carvacrol | HSV-1 | Intercellular | 1.4 | 0.037% |
| 15 | Thymol | HSV-1 | Intercellular | 7 | 0.002% |
| 16 | Eugenol | HSV-1 | Intercellular | 2.4 | 35 μg/mL |
| 17 | HSV-1 | Intercellular | 5 | 20 μg/mL | |
| 18 | β-Eudesmol | HSV-1 | Intercellular | 5.8 | 6 μg/mL |
| 19 | Farnesol | HSV-1 | Intercellular | 11.4 | 3.5 μg/mL |
| 20 | β-Caryophyllene | HSV-1 | Intercellular | 140 | 0.25 μg/mL |
Note: SI = selectivity index, ND = not defined, BVDV = Bovine viral diarrhea virus, HIV = human immunodeficiency viruses, HSV = human herpes viruses, Intracellular = effects on intercellular events of life cycle in viruses, Intercellular = effects on virus surface pre or post adsorption, “a” = later stages of viral lifecycle and “b” = initial stages of viral lifecycle.
Fig. 5Classification of coronaviruses.
Fig. 6General structure of coronaviruses.
The number of cases and deaths in the worst hit countries by COVID-19 in the world [131].
| S. no. | Country | Number of cases | Number of deaths |
|---|---|---|---|
| 1 | United States of America | 6,910,082 | 201,634 |
| 2 | India | 5,903,932 | 93,379 |
| 3 | Brazil | 4,657,702 | 139,808 |
| 4 | Russian Federation | 1,136,048 | 20,056 |
| 5 | Colombia | 790,823 | 24,924 |
| 6 | Peru | 788,930 | 31,938 |
| 7 | Mexico | 715,457 | 75,439 |
| 8 | Spain | 704,209 | 31,118 |
| 9 | Argentina | 678,266 | 14,766 |
| 10 | South Africa | 667,049 | 16,283 |
Fig. 7Representation of different possible modes of action of essential oils and their constituents against SARS-CoV-2.
Fig. 8The biochemical pathways as possible targets for essential oils and their chemical constituents against SARS-CoV-2. The events post SARS-CoV-2 infection in lungs and role of essential oils to suppress its adverse symptoms.